Research graph
References from Cardiovascular and mortality risks following COVID-19–related versus non-COVID-19–related chronic obstructive pulmonary disease exacerbations. Local targets link to admitted publications; unresolved targets remain external evidence.
Increased risk of myocardial infarction and stroke following exacerbation of COPD
10.1378/chest.09-2029 · 2010 · External reference
Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial
10.1164/rccm.201711-2239oc · 2018 · External reference
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
10.1016/s2213-2600(20)30105-3 · 2020 · External reference
Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK routine health care data study
10.2147/copd.s346591 · 2022 · External reference
Cardiovascular disease in COPD
10.1378/chest.12-0938 · 2013 · External reference
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary
10.1183/13993003.00214-2017 · 2017 · External reference
COPD exacerbations: defining their cause and prevention
10.1016/s0140-6736(07)61382-8 · 2007 · External reference
Role of viruses in exacerbations of chronic obstructive pulmonary disease
10.1513/pats.2306030 · 2004 · External reference
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults
10.1177/01410768231184162 · 2023 · External reference
Acute cardiovascular events associated with influenza in hospitalized adults: a cross-sectional study
10.7326/m20-1509 · 2020 · External reference
Cardiovascular consequences of viral infections: from COVID to other viral diseases
10.1093/cvr/cvab315 · 2021 · External reference
10.1016/j.lana.2021.100015 · 2021 · Admitted local publication
The effects of the COVID-19 pandemic on community respiratory virus activity
10.1038/s41579-022-00807-9 · 2023 · External reference
Swedish Covid-19 Investigation for Future Insights—a Population Epidemiology Approach using Register Linkage (SCIFI-PEARL)
10.2147/clep.s312742 · 2021 · External reference
The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research
10.1007/s10654-019-00511-8 · 2019 · External reference
External review and validation of the Swedish national inpatient register
10.1186/1471-2458-11-450 · 2011 · External reference
The new Swedish prescribed drug register—opportunities for pharmacoepidemiological research and experience from the first six months
10.1002/pds.1294 · 2007 · External reference
The Swedish National Airway Register (SNAR): development, design and utility to date
10.1080/20018525.2020.1833412 · 2020 · External reference
Transparent reporting of observational studies emulating a target trial: the TARGET statement
10.1136/bmj-2025-087179 · 2025 · External reference
Medically treated exacerbations in COPD by GOLD 1-4: a valid, robust, and seemingly low-biased definition
10.1016/j.rmed.2015.10.015 · 2015 · External reference
The impact of exacerbation frequency on clinical and economic outcomes in Swedish COPD patients: the ARCTIC study
10.2147/copd.s297943 · 2021 · External reference
Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
10.1186/s12874-021-01440-5 · 2021 · External reference
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
10.1002/sim.6607 · 2015 · External reference
Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis
10.1371/journal.pone.0255659 · 2021 · External reference
Decrease in exacerbations during the coronavirus disease 2019 pandemic in a cohort of veterans with COPD
10.15326/jcopdf.2021.0234 · 2021 · External reference
Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease
10.1101/2023.03.01.23286624 · 2023 · External reference
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease
10.1136/heartjnl-2023-323487 · 2024 · External reference
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD
10.1111/resp.13620 · 2019 · External reference
Myocardial infarction and ischemic stroke after exacerbations of chronic obstructive pulmonary disease
10.1513/annalsats.201710-815oc · 2018 · External reference
SARS-CoV-2 Omicron variant: recent progress and future perspectives
10.1038/s41392-022-00997-x · 2022 · External reference
Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study
10.1016/s0140-6736(21)00896-5 · 2021 · External reference
The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies
10.1183/23120541.01091-2024 · 2025 · External reference
Cardiovascular manifestations of COVID-19 infection
10.3390/cells9112508 · 2020 · External reference
GOLD COPD report: 2025 update
10.1016/s2213-2600(24)00413-2 · 2025 · External reference
Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study
10.1093/eurheartj/ehae639 · 2025 · External reference
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
10.1093/eurheartjsupp/suac123 · 2023 · External reference
COVID-19 testing in Sweden during 2020—split responsibilities and multi-level challenges
10.3389/fpubh.2021.754861 · 2021 · External reference
Graphical depiction of longitudinal study designs in health care databases
10.7326/m18-3079 · 2019 · External reference
